Trevena Inc. (TRVN) NASDAQ
$0.46 0 (0.30%)
Market Cap: $8.40M
As of 03/28/24 03:58 PM EDT. Market closed.
Trevena Inc. (TRVN)
NASDAQ
$0.46
0 (0.30%)
Market Cap: $8.40M
As of 03/28/24 03:58 PM EDT. Market closed.
trevena, inc. is a clinical stage biopharmaceutical company that discovers, develops, and intends to commercialize innovative therapies that use a novel approach to target g protein coupled receptors, or gpcrs. we are dedicated to providing value to patients and healthcare providers by improving patient outcomes and reducing healthcare costs. we have identified four biased ligand drug candidates: ... read more
trevena, inc. is a clinical stage biopharmaceutical company that discovers, develops, and intends to commercialize innovative therapies that use a novel approach to target g protein coupled receptors, or gpcrs. we are dedicated to providing value to patients and healthcare providers by improving patient outcomes and reducing healthcare costs. we have identified four biased ligand drug candidates: trv130, an fda-designated breakthrough therapy, is currently in phase 3 testing for the intravenous treatment of acute moderate to severe pain? trv027 was evaluated in a phase 2b study for the treatment of acute heart failure? trv734 has completed phase 1 testing for oral treatment of acute and chronic pain; and trv250 is in preclinical development for the treatment of migraine. in addition, trevena has an early stage portfolio of drug discovery programs currently in lead optimization. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Drake Patricia M. | SVP, Chief Commercial Officer | Dec 14, 2023 | Option Exercise | $0.61 | 75,000 | 45,750 | 108,913 | Dec 15, 2023, 06:57 PM |
Drake Patricia M. | SVP, Chief Commercial Officer | Dec 14, 2023 | Option Exercise | $0.61 | 1,835 | 1,119 | 107,078 | Dec 15, 2023, 06:57 PM |
Bourdow Carrie L. | President & CEO | Dec 14, 2023 | Option Exercise | $0.61 | 470,000 | 286,700 | 650,046 | Dec 15, 2023, 06:57 PM |
Bourdow Carrie L. | President & CEO | Dec 14, 2023 | Option Exercise | $0.61 | 7,123 | 4,345 | 642,923 | Dec 15, 2023, 06:57 PM |
Shin Barry | SVP, CFO | Dec 14, 2023 | Option Exercise | $0.61 | 235,000 | 143,350 | 312,437 | Dec 15, 2023, 06:57 PM |
Shin Barry | SVP, CFO | Dec 14, 2023 | Option Exercise | $0.61 | 3,616 | 2,206 | 308,821 | Dec 15, 2023, 06:57 PM |
Demitrack Mark | SVP, Chief Medical Officer | Dec 14, 2023 | Option Exercise | $0.61 | 235,000 | 143,350 | 309,817 | Dec 15, 2023, 06:56 PM |
Demitrack Mark | SVP, Chief Medical Officer | Dec 14, 2023 | Option Exercise | $0.61 | 3,593 | 2,192 | 306,224 | Dec 15, 2023, 06:56 PM |
Yoder Robert T | SVP, Chief Business Officer | Dec 14, 2023 | Option Exercise | $0.61 | 117,500 | 71,675 | 160,806 | Dec 15, 2023, 06:56 PM |
Yoder Robert T | SVP, Chief Business Officer | Dec 14, 2023 | Option Exercise | $0.61 | 1,929 | 1,177 | 158,877 | Dec 15, 2023, 06:56 PM |
Bourdow Carrie L. | President & CEO | Dec 02, 2023 | Option Exercise | $0.59 | 12,028 | 7,097 | 190,731 | Dec 05, 2023, 05:51 PM |
Yoder Robert T | SVP, Chief Business Officer | Dec 02, 2023 | Option Exercise | $0.59 | 3,106 | 1,833 | 45,976 | Dec 05, 2023, 05:50 PM |
Shin Barry | SVP, CFO | Dec 02, 2023 | Option Exercise | $0.59 | 5,036 | 2,971 | 82,066 | Dec 05, 2023, 05:50 PM |
Demitrack Mark | SVP, Chief Medical Officer | Dec 02, 2023 | Option Exercise | $0.59 | 5,211 | 3,074 | 79,531 | Dec 05, 2023, 05:49 PM |
Drake Patricia M. | SVP, Chief Commercial Officer | Dec 02, 2023 | Option Exercise | $0.59 | 2,129 | 1,256 | 35,748 | Dec 05, 2023, 05:47 PM |
Drake Patricia M. | SVP, Chief Commercial Officer | Nov 10, 2023 | Option Exercise | $0.57 | 632 | 360 | 36,042 | Nov 14, 2023, 04:11 PM |
Shin Barry | SVP, CFO | Sep 14, 2023 | Option Exercise | $0.70 | 72 | 50 | 82,473 | Sep 18, 2023, 05:26 PM |
Shin Barry | SVP, CFO | Jun 26, 2023 | Option Exercise | $0.84 | 722 | 606 | 82,545 | Jun 28, 2023, 04:17 PM |
Bourdow Carrie L. | President & CEO | Dec 17, 2022 | Option Exercise | $1.55 | 1,342 | 2,080 | 92,074 | Dec 20, 2022, 04:33 PM |
Shin Barry | SVP, CFO | Dec 17, 2022 | Option Exercise | $1.55 | 413 | 640 | 33,267 | Dec 20, 2022, 04:32 PM |
Yoder Robert T | SVP, Chief Business Officer | Dec 17, 2022 | Option Exercise | $1.55 | 443 | 687 | 21,412 | Dec 20, 2022, 04:31 PM |
Demitrack Mark | SVP, Chief Medical Officer | Dec 17, 2022 | Option Exercise | $1.55 | 497 | 770 | 30,028 | Dec 20, 2022, 04:31 PM |
Bourdow Carrie L. | President & CEO | Dec 02, 2022 | Option Exercise | $3.42 | 3,560 | 12,175 | 93,416 | Dec 06, 2022, 04:32 PM |
Demitrack Mark | SVP, Chief Medical Officer | Dec 02, 2022 | Option Exercise | $3.42 | 1,121 | 3,834 | 30,525 | Dec 06, 2022, 04:28 PM |
Drake Patricia M. | SVP, Chief Commercial Officer | Dec 02, 2022 | Option Exercise | $3.42 | 294 | 1,005 | 11,674 | Dec 06, 2022, 04:28 PM |
Yoder Robert T | SVP, Chief Business Officer | Dec 02, 2022 | Option Exercise | $3.42 | 753 | 2,575 | 21,855 | Dec 06, 2022, 04:27 PM |
Shin Barry | SVP, CFO | Dec 02, 2022 | Option Exercise | $3.42 | 1,170 | 4,001 | 33,680 | Dec 06, 2022, 04:27 PM |
Drake Patricia M. | SVP, Chief Commercial Officer | Nov 10, 2022 | Option Exercise | $2.47 | 632 | 1,561 | 11,968 | Nov 15, 2022, 06:53 PM |
Shin Barry | SVP, CFO | Sep 14, 2022 | Option Exercise | $0.21 | 1,792 | 369 | 871,264 | Sep 16, 2022, 10:54 AM |
Shin Barry | SVP, CFO | Jun 28, 2022 | Sale | $0.41 | 31,785 | 13,032 | 873,056 | Jun 29, 2022, 05:12 PM |
Bourdow Carrie L. | President & CEO | Dec 17, 2021 | Option Exercise | $0.70 | 33,546 | 23,482 | 2,424,403 | Dec 21, 2021, 04:17 PM |
Demitrack Mark | SVP, Chief Medical Officer | Dec 17, 2021 | Option Exercise | $0.70 | 12,408 | 8,686 | 791,172 | Dec 21, 2021, 04:16 PM |
Yoder Robert T | SVP, Chief Business Officer | Dec 17, 2021 | Option Exercise | $0.70 | 9,711 | 6,798 | 565,205 | Dec 21, 2021, 04:11 PM |
Shin Barry | SVP, CFO | Dec 17, 2021 | Option Exercise | $0.70 | 14,216 | 9,951 | 904,841 | Dec 21, 2021, 04:10 PM |
Demitrack Mark | SVP, Chief Medical Officer | Dec 06, 2021 | Option Exercise | $0.65 | 30,601 | 19,891 | 803,580 | Dec 08, 2021, 04:17 PM |
Yoder Robert T | SVP, Chief Business Officer | Dec 06, 2021 | Option Exercise | $0.65 | 22,950 | 14,917 | 574,916 | Dec 08, 2021, 04:17 PM |
Shin Barry | SVP, CFO & CCO | Dec 06, 2021 | Option Exercise | $0.65 | 34,408 | 22,365 | 919,057 | Dec 08, 2021, 04:16 PM |
Bourdow Carrie L. | President & CEO | Dec 06, 2021 | Option Exercise | $0.65 | 93,561 | 60,815 | 2,457,949 | Dec 08, 2021, 04:16 PM |
Bourdow Carrie L. | President & CEO | Jun 28, 2021 | Buy | $1.79 | 56,200 | 100,542 | 1,301,510 | Jun 28, 2021, 05:33 PM |
Shin Barry | Chief Financial Officer | Jun 25, 2021 | Option Exercise | $1.96 | 24,635 | 48,285 | 535,965 | Jun 25, 2021, 05:49 PM |
Applebaum Scott | CLCO; SVP, Regulatory Affairs | Feb 10, 2021 | Option Exercise | $2.85 | 21,178 | 60,357 | 344,022 | Feb 12, 2021, 04:17 PM |
Bourdow Carrie L. | President & CEO | Dec 07, 2020 | Option Exercise | $2.27 | 151,684 | 344,323 | 1,245,310 | Dec 31, 2020, 04:52 PM |
Yoder Robert T | Sr VP Chief Commercial Officer | Dec 07, 2020 | Option Exercise | $2.27 | 36,688 | 83,282 | 216,566 | Dec 09, 2020, 04:43 PM |
Demitrack Mark | Sr. VP & Chief Medical Officer | Dec 07, 2020 | Option Exercise | $2.27 | 48,557 | 110,224 | 271,481 | Dec 09, 2020, 04:38 PM |
Bourdow Carrie L. | President & CEO | Dec 07, 2020 | Option Exercise | $2.27 | 132,934 | 301,760 | 792,960 | Dec 09, 2020, 04:37 PM |
Shin Barry | Chief Financial Officer | Dec 07, 2020 | Option Exercise | $2.27 | 41,861 | 95,024 | 403,600 | Dec 09, 2020, 04:35 PM |
Shin Barry | Chief Financial Officer | Jun 25, 2020 | Option Exercise | $1.72 | 23,539 | 40,487 | 445,461 | Jun 29, 2020, 07:49 PM |
Yoder Robert T | Sr. VP, Chief Business Officer | Dec 02, 2019 | Option Exercise | $0.69 | 6,874 | 4,735 | 86,254 | Dec 04, 2019, 05:48 PM |
Demitrack Mark | Sr. VP & Chief Medical Officer | Dec 02, 2019 | Option Exercise | $0.69 | 8,982 | 6,188 | 107,038 | Dec 04, 2019, 05:47 PM |
Bourdow Carrie L. | President and CEO | Dec 02, 2019 | Option Exercise | $0.69 | 17,804 | 12,265 | 268,894 | Dec 04, 2019, 05:46 PM |
Demitrack Mark | Sr VP & Chief Medical Officer | Jun 03, 2019 | Option Exercise | $1.17 | 8,980 | 10,507 | 116,020 | Jun 04, 2019, 04:53 PM |
Hamill John P. | VP Fin,Princ Fin&Acct Officer | Jun 03, 2019 | Option Exercise | $1.17 | 5,516 | 6,454 | 82,234 | Jun 04, 2019, 04:52 PM |
Hamill John P. | VP Fin,Princ Fin&Acct Officer | May 31, 2019 | Buy | $1.16 | 7,500 | 8,700 | 87,750 | Jun 04, 2019, 04:52 PM |
Yoder Robert T | Sr. VP, Chief Business Officer | Jun 03, 2019 | Option Exercise | $1.17 | 6,872 | 8,040 | 93,128 | Jun 04, 2019, 04:51 PM |
Bourdow Carrie L. | President and CEO | Jun 03, 2019 | Option Exercise | $1.17 | 17,802 | 20,828 | 286,698 | Jun 04, 2019, 04:49 PM |
GOWEN MAXINE | President & CEO | Feb 01, 2019 | Buy | $1.02 | 50,000 | 51,000 | 54,000 | Feb 05, 2019, 04:59 PM |
Bourdow Carrie L. | President and CEO | Feb 01, 2019 | Option Exercise | $1.02 | 50,000 | 51,000 | 304,500 | Feb 05, 2019, 08:41 AM |
MOULDER LEON O JR | Director | Feb 01, 2019 | Buy | $1.02 | 100,000 | 102,000 | 100,000 | Feb 04, 2019, 09:01 AM |
Habib Yacoub | SVP, Bus Dev & Corp Planning | Mar 22, 2018 | Sale | $1.76 | 5,000 | 8,800 | 0 | Mar 23, 2018, 05:16 PM |
GOWEN MAXINE | President & CEO | Feb 23, 2017 | Option Exercise | $0.68 | 110,403 | 75,295 | 126,903 | Feb 27, 2017, 08:34 AM |
Lark Michael W. | Sr. VP, Research & CSO | Feb 10, 2017 | Option Exercise | $0.68 | 12,815 | 8,740 | 98,460 | Feb 14, 2017, 05:20 PM |
Lark Michael W. | Sr. VP, Research & CSO | Feb 10, 2017 | Sale | $8.00 | 23,699 | 189,592 | 74,761 | Feb 14, 2017, 05:20 PM |
Bourdow Carrie L. | SVP, Chief Commercial Officer | Nov 09, 2016 | Buy | $4.34 | 4,000 | 17,360 | 4,500 | Nov 10, 2016, 06:12 PM |
GOWEN MAXINE | President & CEO | Nov 07, 2016 | Buy | $4.10 | 12,500 | 51,250 | 16,500 | Nov 09, 2016, 05:37 PM |
Habib Yacoub | SVP, Bus Dev & Corp Planning | Nov 07, 2016 | Buy | $4.12 | 5,000 | 20,600 | 5,000 | Nov 09, 2016, 05:36 PM |
GOWEN MAXINE | President & CEO | May 27, 2016 | Buy | $7.08 | 14,084 | 99,715 | 293,109 | May 31, 2016, 05:34 PM |
GOWEN MAXINE | President & CEO | May 26, 2016 | Buy | $7.20 | 4,000 | 28,800 | 4,000 | May 31, 2016, 05:34 PM |
GOWEN MAXINE | President & CEO | May 26, 2016 | Buy | $7.19 | 4,000 | 28,760 | 279,025 | May 31, 2016, 05:34 PM |
Soergel David | Sr. VP,Clinical Dev. & CMO | Dec 10, 2015 | Sale | $10.55 | 27,217 | 287,139 | 1,750 | Dec 11, 2015, 05:17 PM |
Limongelli John M | Sr. VP,General Counsel & Secy | Dec 12, 2014 | Buy | $4.14 | 3,000 | 12,420 | 12,000 | Dec 15, 2014, 05:00 PM |
MOULDER LEON O JR | Director | Dec 09, 2014 | Buy | $3.96 | 30,200 | 119,592 | 30,200 | Dec 10, 2014, 08:39 PM |
MOULDER LEON O JR | Director | Dec 10, 2014 | Buy | $4.06 | 19,800 | 80,388 | 50,000 | Dec 10, 2014, 08:39 PM |
Soergel David | Sr. VP, Clinical Development | Dec 10, 2014 | Buy | $4.00 | 1,250 | 5,000 | 28,967 | Dec 10, 2014, 08:37 PM |
Soergel David | Sr. VP, Clinical Development | Dec 09, 2014 | Buy | $3.97 | 500 | 1,985 | 27,717 | Dec 10, 2014, 08:37 PM |
Limongelli John M | Sr. VP,General Counsel & Secy | Dec 10, 2014 | Buy | $4.00 | 9,000 | 36,000 | 9,000 | Dec 10, 2014, 06:07 PM |
Cuca Roberto | Sr. VP and CFO | Dec 10, 2014 | Buy | $4.00 | 25,000 | 100,000 | 25,000 | Dec 10, 2014, 06:05 PM |
Yanni Barbara | Director | Dec 10, 2014 | Buy | $4.00 | 1,250 | 5,000 | 1,250 | Dec 10, 2014, 06:03 PM |
DOUGHERTY MICHAEL R | Director | Dec 10, 2014 | Buy | $4.00 | 7,000 | 28,000 | 7,000 | Dec 10, 2014, 06:01 PM |
Soergel David | Sr. VP, Clinical Development | Dec 10, 2014 | Buy | $4.00 | 1,250 | 5,000 | 28,467 | Dec 10, 2014, 05:59 PM |
Lark Michael W. | Sr. VP, Research & CSO | Dec 10, 2014 | Buy | $4.00 | 5,000 | 20,000 | 85,645 | Dec 10, 2014, 05:56 PM |
GOWEN MAXINE | President & CEO | Dec 10, 2014 | Buy | $4.00 | 8,000 | 32,000 | 326,025 | Dec 10, 2014, 05:54 PM |
Alta Partners VIII, L.P. | 10% Owner | Dec 10, 2014 | Buy | $4.00 | 500,000 | 2,000,000 | 4,390,262 | Dec 10, 2014, 05:51 PM |
New Enterprise Associates 12, Limited Partnership | 10% Owner | Dec 10, 2014 | Buy | $4.00 | 1,000,000 | 4,000,000 | 4,811,691 | Dec 10, 2014, 12:13 PM |
Deegan Rosamond | Sr VP, Bus Dev & Operations | Sep 29, 2014 | Sale | $7.00 | 44 | 308 | 31,105 | Oct 01, 2014, 04:48 PM |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | Aug 14, 2014 | Sale | $6.04 | 36,702 | 221,680 | 3,637,115 | Aug 18, 2014, 04:30 PM |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | Aug 13, 2014 | Sale | $6.12 | 5,700 | 34,884 | 3,672,530 | Aug 15, 2014, 04:30 PM |
GOWEN MAXINE | President & CEO | Apr 23, 2014 | Option Exercise | $0.68 | 124,477 | 84,893 | 318,025 | May 15, 2014, 09:37 PM |
Forest Laboratories Holdings Ltd | 10% Owner | Feb 05, 2014 | Buy | $7.00 | 428,571 | 2,999,997 | 3,393,466 | Feb 07, 2014, 01:14 PM |
New Enterprise Associates 12, Limited Partnership | 10% Owner | Feb 05, 2014 | Buy | $7.00 | 472,410 | 3,306,870 | 3,811,691 | Feb 07, 2014, 12:16 PM |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | Feb 05, 2014 | Buy | $7.00 | 472,405 | 3,306,835 | 3,811,682 | Feb 07, 2014, 12:06 PM |
HealthCare Ventures VIII, L.P. | 10% Owner | Feb 05, 2014 | Buy | $7.00 | 297,058 | 2,079,406 | 2,446,251 | Feb 07, 2014, 12:02 PM |
Alta Partners VIII, L.P. | 10% Owner | Feb 05, 2014 | Buy | $7.00 | 472,410 | 3,306,870 | 3,890,262 | Feb 07, 2014, 11:57 AM |
Owner | Relationship | Date | Value($) |
Drake Patricia M. | SVP, Chief Commercial Officer | 12/14/2023 | 45,750 |
Drake Patricia M. | SVP, Chief Commercial Officer | 12/14/2023 | 1,119 |
Bourdow Carrie L. | President & CEO | 12/14/2023 | 286,700 |
Bourdow Carrie L. | President & CEO | 12/14/2023 | 4,345 |
Shin Barry | SVP, CFO | 12/14/2023 | 143,350 |
Shin Barry | SVP, CFO | 12/14/2023 | 2,206 |
Demitrack Mark | SVP, Chief Medical Officer | 12/14/2023 | 143,350 |
Demitrack Mark | SVP, Chief Medical Officer | 12/14/2023 | 2,192 |
Yoder Robert T | SVP, Chief Business Officer | 12/14/2023 | 71,675 |
Yoder Robert T | SVP, Chief Business Officer | 12/14/2023 | 1,177 |
Bourdow Carrie L. | President & CEO | 12/02/2023 | 7,097 |
Yoder Robert T | SVP, Chief Business Officer | 12/02/2023 | 1,833 |
Shin Barry | SVP, CFO | 12/02/2023 | 2,971 |
Demitrack Mark | SVP, Chief Medical Officer | 12/02/2023 | 3,074 |
Drake Patricia M. | SVP, Chief Commercial Officer | 12/02/2023 | 1,256 |
Drake Patricia M. | SVP, Chief Commercial Officer | 11/10/2023 | 360 |
Shin Barry | SVP, CFO | 09/14/2023 | 50 |
Shin Barry | SVP, CFO | 06/26/2023 | 606 |
Bourdow Carrie L. | President & CEO | 12/17/2022 | 2,080 |
Shin Barry | SVP, CFO | 12/17/2022 | 640 |
Yoder Robert T | SVP, Chief Business Officer | 12/17/2022 | 687 |
Demitrack Mark | SVP, Chief Medical Officer | 12/17/2022 | 770 |
Bourdow Carrie L. | President & CEO | 12/02/2022 | 12,175 |
Demitrack Mark | SVP, Chief Medical Officer | 12/02/2022 | 3,834 |
Drake Patricia M. | SVP, Chief Commercial Officer | 12/02/2022 | 1,005 |
Yoder Robert T | SVP, Chief Business Officer | 12/02/2022 | 2,575 |
Shin Barry | SVP, CFO | 12/02/2022 | 4,001 |
Drake Patricia M. | SVP, Chief Commercial Officer | 11/10/2022 | 1,561 |
Shin Barry | SVP, CFO | 09/14/2022 | 369 |
Shin Barry | SVP, CFO | 06/28/2022 | 13,032 |
Bourdow Carrie L. | President & CEO | 12/17/2021 | 23,482 |
Demitrack Mark | SVP, Chief Medical Officer | 12/17/2021 | 8,686 |
Yoder Robert T | SVP, Chief Business Officer | 12/17/2021 | 6,798 |
Shin Barry | SVP, CFO | 12/17/2021 | 9,951 |
Demitrack Mark | SVP, Chief Medical Officer | 12/06/2021 | 19,891 |
Yoder Robert T | SVP, Chief Business Officer | 12/06/2021 | 14,917 |
Shin Barry | SVP, CFO & CCO | 12/06/2021 | 22,365 |
Bourdow Carrie L. | President & CEO | 12/06/2021 | 60,815 |
Bourdow Carrie L. | President & CEO | 06/28/2021 | 100,542 |
Shin Barry | Chief Financial Officer | 06/25/2021 | 48,285 |
Applebaum Scott | CLCO; SVP, Regulatory Affairs | 02/10/2021 | 60,357 |
Bourdow Carrie L. | President & CEO | 12/07/2020 | 344,323 |
Yoder Robert T | Sr VP Chief Commercial Officer | 12/07/2020 | 83,282 |
Demitrack Mark | Sr. VP & Chief Medical Officer | 12/07/2020 | 110,224 |
Bourdow Carrie L. | President & CEO | 12/07/2020 | 301,760 |
Shin Barry | Chief Financial Officer | 12/07/2020 | 95,024 |
Shin Barry | Chief Financial Officer | 06/25/2020 | 40,487 |
Yoder Robert T | Sr. VP, Chief Business Officer | 12/02/2019 | 4,735 |
Demitrack Mark | Sr. VP & Chief Medical Officer | 12/02/2019 | 6,188 |
Bourdow Carrie L. | President and CEO | 12/02/2019 | 12,265 |
Demitrack Mark | Sr VP & Chief Medical Officer | 06/03/2019 | 10,507 |
Hamill John P. | VP Fin,Princ Fin&Acct Officer | 06/03/2019 | 6,454 |
Hamill John P. | VP Fin,Princ Fin&Acct Officer | 05/31/2019 | 8,700 |
Yoder Robert T | Sr. VP, Chief Business Officer | 06/03/2019 | 8,040 |
Bourdow Carrie L. | President and CEO | 06/03/2019 | 20,828 |
GOWEN MAXINE | President & CEO | 02/01/2019 | 51,000 |
Bourdow Carrie L. | President and CEO | 02/01/2019 | 51,000 |
MOULDER LEON O JR | Director | 02/01/2019 | 102,000 |
Habib Yacoub | SVP, Bus Dev & Corp Planning | 03/22/2018 | 8,800 |
GOWEN MAXINE | President & CEO | 02/23/2017 | 75,295 |
Lark Michael W. | Sr. VP, Research & CSO | 02/10/2017 | 8,740 |
Lark Michael W. | Sr. VP, Research & CSO | 02/10/2017 | 189,592 |
Bourdow Carrie L. | SVP, Chief Commercial Officer | 11/09/2016 | 17,360 |
GOWEN MAXINE | President & CEO | 11/07/2016 | 51,250 |
Habib Yacoub | SVP, Bus Dev & Corp Planning | 11/07/2016 | 20,600 |
GOWEN MAXINE | President & CEO | 05/27/2016 | 99,715 |
GOWEN MAXINE | President & CEO | 05/26/2016 | 28,800 |
GOWEN MAXINE | President & CEO | 05/26/2016 | 28,760 |
Soergel David | Sr. VP,Clinical Dev. & CMO | 12/10/2015 | 287,139 |
Limongelli John M | Sr. VP,General Counsel & Secy | 12/12/2014 | 12,420 |
MOULDER LEON O JR | Director | 12/09/2014 | 119,592 |
MOULDER LEON O JR | Director | 12/10/2014 | 80,388 |
Soergel David | Sr. VP, Clinical Development | 12/10/2014 | 5,000 |
Soergel David | Sr. VP, Clinical Development | 12/09/2014 | 1,985 |
Limongelli John M | Sr. VP,General Counsel & Secy | 12/10/2014 | 36,000 |
Cuca Roberto | Sr. VP and CFO | 12/10/2014 | 100,000 |
Yanni Barbara | Director | 12/10/2014 | 5,000 |
DOUGHERTY MICHAEL R | Director | 12/10/2014 | 28,000 |
Soergel David | Sr. VP, Clinical Development | 12/10/2014 | 5,000 |
Lark Michael W. | Sr. VP, Research & CSO | 12/10/2014 | 20,000 |
GOWEN MAXINE | President & CEO | 12/10/2014 | 32,000 |
Alta Partners VIII, L.P. | 10% Owner | 12/10/2014 | 2,000,000 |
New Enterprise Associates 12, Limited Partnership | 10% Owner | 12/10/2014 | 4,000,000 |
Deegan Rosamond | Sr VP, Bus Dev & Operations | 09/29/2014 | 308 |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | 08/14/2014 | 221,680 |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | 08/13/2014 | 34,884 |
GOWEN MAXINE | President & CEO | 04/23/2014 | 84,893 |
Forest Laboratories Holdings Ltd | 10% Owner | 02/05/2014 | 2,999,997 |
New Enterprise Associates 12, Limited Partnership | 10% Owner | 02/05/2014 | 3,306,870 |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | 02/05/2014 | 3,306,835 |
HealthCare Ventures VIII, L.P. | 10% Owner | 02/05/2014 | 2,079,406 |
Alta Partners VIII, L.P. | 10% Owner | 02/05/2014 | 3,306,870 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | 151,552 | 0.00017% | -14.6% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 115,575 | 0.00001% | 29.49% | Other |
BLACKROCK INC. | 107,929 | 0% | -3.65% | Other |